Aortic stenosis cardiac catheterization: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]=== | ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]=== | ||
'''1.''' ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) | '''1.''' Coronary angiography is recommended before AVR in patients with AS at risk for CAD. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) | ||
'''2.''' ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | '''2.''' Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | ||
'''3.''' ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | '''3.''' Coronary angiography is recommended before AVR in patients with AS for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | ||
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]]=== | ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]]=== | ||
Revision as of 18:08, 4 November 2011
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis cardiac catheterization On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis cardiac catheterization |
|
Directions to Hospitals Treating Aortic stenosis cardiac catheterization |
|
Risk calculators and risk factors for Aortic stenosis cardiac catheterization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Claudia P. Hochberg, M.D. [2]; Abdul-Rahman Arabi, M.D. [3], Keri Shafer, M.D. [4], Priyamvada Singh, MBBS [5]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [6]
Overview
Cardiac catheterization, such as angiography, may be used as a diagnostic tool in the evaluation of aortic stenosis. Angiographic findings associated with aortic stenosis include left ventricular hypertrophy and heart block.
Cardiac Catheterization
Simultaneous left ventricular and aortic pressure tracings demonstrate a pressure gradient between the left ventricle and aorta, suggesting aortic stenosis. The left ventricle generates higher pressures than what is transmitted to the aorta. The pressure gradient, caused by aortic stenosis, is represented by the green shaded area. (AO = ascending aorta; LV = left ventricle; ECG = electrocardiogram.) The heart may be catheterized to directly measure the pressure on both sides of the aortic valve. The pressure gradient may be used as a decision point for treatment. Catheterization is accurate for moderate velocity stenosis, while Doppler echo is more accurate at faster velocities.
ACC/AHA Guidelines- Indications for Cardiac Catheterization (DO NOT EDIT) [1]
| “ |
Class I1. Coronary angiography is recommended before AVR in patients with AS at risk for CAD. (Level of Evidence: B) 2. Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. (Level of Evidence: C) 3. Coronary angiography is recommended before AVR in patients with AS for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. (Level of Evidence: C) Class III1. (Level of Evidence: C) 2. (Level of Evidence: C) |
” |
References
- ↑ Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (13): e1–142. doi:10.1016/j.jacc.2008.05.007. PMID 18848134.